INNOCAN PHARMA CORPORATION financial statements, including revenue, expenses, profit, and loss

The total revenue of INNO for the last quarter is 11.83 M CAD, and it's 29.58% higher compared to the previous quarter. The net income of Q2 24 is 461.11 k CAD.